Molecules of the Month – June 2023
Drug Hunter
JULY 21, 2023
With the popular success of diabetes and weight-loss peptide drugs from Novo (e.g. danuglipron – An oral GLP-1-RA full agonist in Phase IIb clinical trials for obesity and Phase II trials for type 2 diabetes mellitus, identified through sensitized cell high-throughput screening and optimization, originated from Pfizer.
Let's personalize your content